IBDEI1UP ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29562,2)
 ;;=^5003387
 ;;^UTILITY(U,$J,358.3,29563,0)
 ;;=F18.259^^118^1491^14
 ;;^UTILITY(U,$J,358.3,29563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29563,1,3,0)
 ;;=3^Inhalant Induced Psychotic D/O w/ Mod/Sev Use D/O
 ;;^UTILITY(U,$J,358.3,29563,1,4,0)
 ;;=4^F18.259
 ;;^UTILITY(U,$J,358.3,29563,2)
 ;;=^5003400
 ;;^UTILITY(U,$J,358.3,29564,0)
 ;;=F18.959^^118^1491^15
 ;;^UTILITY(U,$J,358.3,29564,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29564,1,3,0)
 ;;=3^Inhalant Induced Psychotic D/O w/o Use D/O
 ;;^UTILITY(U,$J,358.3,29564,1,4,0)
 ;;=4^F18.959
 ;;^UTILITY(U,$J,358.3,29564,2)
 ;;=^5003412
 ;;^UTILITY(U,$J,358.3,29565,0)
 ;;=F18.99^^118^1491^22
 ;;^UTILITY(U,$J,358.3,29565,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29565,1,3,0)
 ;;=3^Inhalant Related D/O,Unspec
 ;;^UTILITY(U,$J,358.3,29565,1,4,0)
 ;;=4^F18.99
 ;;^UTILITY(U,$J,358.3,29565,2)
 ;;=^5133360
 ;;^UTILITY(U,$J,358.3,29566,0)
 ;;=F18.21^^118^1491^25
 ;;^UTILITY(U,$J,358.3,29566,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29566,1,3,0)
 ;;=3^Inhalant Use D/O,Mod/Sev,In Remission
 ;;^UTILITY(U,$J,358.3,29566,1,4,0)
 ;;=4^F18.21
 ;;^UTILITY(U,$J,358.3,29566,2)
 ;;=^5003393
 ;;^UTILITY(U,$J,358.3,29567,0)
 ;;=F18.11^^118^1491^24
 ;;^UTILITY(U,$J,358.3,29567,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29567,1,3,0)
 ;;=3^Inhalant Use D/O,Mild,In Remission
 ;;^UTILITY(U,$J,358.3,29567,1,4,0)
 ;;=4^F18.11
 ;;^UTILITY(U,$J,358.3,29567,2)
 ;;=^5151305
 ;;^UTILITY(U,$J,358.3,29568,0)
 ;;=Z00.6^^118^1492^1
 ;;^UTILITY(U,$J,358.3,29568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29568,1,3,0)
 ;;=3^Exam Control in Clinical Research
 ;;^UTILITY(U,$J,358.3,29568,1,4,0)
 ;;=4^Z00.6
 ;;^UTILITY(U,$J,358.3,29568,2)
 ;;=^5062608
 ;;^UTILITY(U,$J,358.3,29569,0)
 ;;=F45.8^^118^1493^13
 ;;^UTILITY(U,$J,358.3,29569,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29569,1,3,0)
 ;;=3^Somatoform Symp & Rel D/O,Oth Spec
 ;;^UTILITY(U,$J,358.3,29569,1,4,0)
 ;;=4^F45.8
 ;;^UTILITY(U,$J,358.3,29569,2)
 ;;=^331915
 ;;^UTILITY(U,$J,358.3,29570,0)
 ;;=F45.0^^118^1493^12
 ;;^UTILITY(U,$J,358.3,29570,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29570,1,3,0)
 ;;=3^Somatization D/O
 ;;^UTILITY(U,$J,358.3,29570,1,4,0)
 ;;=4^F45.0
 ;;^UTILITY(U,$J,358.3,29570,2)
 ;;=^112280
 ;;^UTILITY(U,$J,358.3,29571,0)
 ;;=F45.9^^118^1493^14
 ;;^UTILITY(U,$J,358.3,29571,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29571,1,3,0)
 ;;=3^Somatoform Symp & Rel D/O,Unspec
 ;;^UTILITY(U,$J,358.3,29571,1,4,0)
 ;;=4^F45.9
 ;;^UTILITY(U,$J,358.3,29571,2)
 ;;=^5003592
 ;;^UTILITY(U,$J,358.3,29572,0)
 ;;=F45.1^^118^1493^11
 ;;^UTILITY(U,$J,358.3,29572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29572,1,3,0)
 ;;=3^Somatic Symptom D/O
 ;;^UTILITY(U,$J,358.3,29572,1,4,0)
 ;;=4^F45.1
 ;;^UTILITY(U,$J,358.3,29572,2)
 ;;=^5003585
 ;;^UTILITY(U,$J,358.3,29573,0)
 ;;=F44.4^^118^1493^4
 ;;^UTILITY(U,$J,358.3,29573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29573,1,3,0)
 ;;=3^Conversion D/O w/ Motor Symp or Deficit
 ;;^UTILITY(U,$J,358.3,29573,1,4,0)
 ;;=4^F44.4
 ;;^UTILITY(U,$J,358.3,29573,2)
 ;;=^5003579
 ;;^UTILITY(U,$J,358.3,29574,0)
 ;;=F44.6^^118^1493^1
 ;;^UTILITY(U,$J,358.3,29574,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29574,1,3,0)
 ;;=3^Conversion D/O w/ Anesthesia or Sensory Loss
 ;;^UTILITY(U,$J,358.3,29574,1,4,0)
 ;;=4^F44.6
 ;;^UTILITY(U,$J,358.3,29574,2)
 ;;=^5003581
